Alternatives to PAIN Act

This bill (S 3832) creates new Medicare Part D coverage rules for specific non-opioid pain management drugs starting in 2025. It requires Medicare plans to waive deductibles and place these drugs on the lowest copay tier for beneficiaries, while banning step therapy (forcing opioid use first) and prior authorization for them. The bill applies to Medicare Part D beneficiaries seeking pain treatment and directly affects Medicare plans' coverage rules. To qualify, drugs must be FDA-approved for pain, non-opioid, have no equally effective alternative drug available, and meet cost limits set by the government.